ANTIBODY MEDIATED REJECTION
Clinical trials for ANTIBODY MEDIATED REJECTION explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY MEDIATED REJECTION trials appear
Sign up with your email to follow new studies for ANTIBODY MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients facing rejection
Disease control OngoingThis study tests a new drug called ALXN2030 in 45 adults who have had a kidney transplant and are experiencing antibody-mediated rejection (AMR). The goal is to see if the drug can help resolve signs of rejection seen on a kidney biopsy after one year of treatment. Participants w…
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new drug combo save failing kidney transplants?
Disease control OngoingThis phase 3 trial is testing whether adding tocilizumab to standard care can slow the decline in kidney function for people who have chronic antibody-mediated rejection after a kidney transplant. Half of the 50 participants will receive tocilizumab plus standard care, while the …
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: PHASE3 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for kidney transplant patients: extended drug trial targets rejection
Disease control ENROLLING_BY_INVITATIONThis study offers kidney transplant patients with antibody-mediated rejection (AMR) the chance to receive felzartamab for up to 4 more years. AMR occurs when the immune system attacks the new kidney. The main goal is to check long-term safety and monitor kidney health through bio…
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New shot could help kidney transplant patients fight rejection
Disease control OngoingThis study tests a drug called efgartigimod, given as a shot under the skin, for people who have antibody-mediated rejection after a kidney transplant. The trial includes 30 adults who received a kidney at least 6 months ago and have signs of rejection. Participants will receive …
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug could save transplanted kidneys from rejection
Disease control OngoingThis study tests a drug called felzartamab in people who received a kidney transplant and later developed antibody-mediated rejection (AMR), where the immune system attacks the new kidney. The drug targets immune cells that make harmful antibodies, aiming to reduce kidney damage …
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Gene clues may explain why light therapy helps some transplant patients
Knowledge-focused OngoingThis study looks at gene activity in blood cells from 30 kidney or lung transplant patients who have chronic rejection. Researchers want to find out why some patients improve with a treatment called extracorporeal photoapheresis (ECP) while others do not. The goal is to better un…
Matched conditions: ANTIBODY MEDIATED REJECTION
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC